Skip to main content
OpenTrials
Completed

NCT Number: NCT00206895

Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study

The purpose of the study is to evaluated the efficacy and tolerability of methyl aminolevulinate and 5-aminolevulinic acid photodynamic therapy in patients with moderate to severe facial acne vulgaris in a randomized controlled and investigator blinded trial.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bispebjerg Hospital

Copenhagen, Copenhagen NV, 2400, Denmark

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 years or older, good health, more than 12 inflammatory facial acne lesions -

Exclusion criteria

skin type VI, pregnant or lactating woman. Oral retinoid use within one year, systemic antibiotics within 1 month, topical acne treatment within 2 weeks.

-

Treatment and study plan

Photodynamic Therapy

Procedure

Primary outcomes

  1. Lesion counts (non-inflammatory and inflammatory)

  2. Leeds Revised Acne Grading System

Secondary outcomes

  1. Pain

  2. Side effects

Sponsors and collaborators

Lead sponsor

Bispebjerg Hospital

Other

Registry information

Important dates

Study start
2004
First posted
Sep 21, 2005
Registry last updated
Oct 11, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.